128 related articles for article (PubMed ID: 35993583)
1. Targeted Alpha Therapy of Glioma Using
Liu W; Ma H; Liang R; Chen X; Li H; Lan T; Yang J; Liao J; Qin Z; Yang Y; Liu N; Li F
Mol Pharm; 2022 Sep; 19(9):3206-3216. PubMed ID: 35993583
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of VEGFR and integrins in glioma tumor xenografts using
Liu W; Ma H; Li F; Cai H; Liang R; Chen X; Lan T; Yang J; Liao J; Yang Y; Liu N
Bioorg Med Chem; 2022 Apr; 59():116677. PubMed ID: 35220162
[TBL] [Abstract][Full Text] [Related]
3. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
[TBL] [Abstract][Full Text] [Related]
4. Tumor targeting DVDMS-nanoliposomes for an enhanced sonodynamic therapy of gliomas.
Sun Y; Wang H; Wang P; Zhang K; Geng X; Liu Q; Wang X
Biomater Sci; 2019 Feb; 7(3):985-994. PubMed ID: 30601475
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of
Ma H; Li F; Shen G; Pan L; Liu W; Liang R; Lan T; Yang Y; Yang J; Liao J; Liu N
Bioorg Med Chem; 2022 Feb; 55():116600. PubMed ID: 34999526
[TBL] [Abstract][Full Text] [Related]
6. Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins.
Ocampo-García BE; Santos-Cuevas CL; De León-Rodríguez LM; García-Becerra R; Ordaz-Rosado D; Luna-Guitiérrez MA; Jiménez-Mancilla NP; Romero-Piña ME; Ferro-Flores G
Nucl Med Biol; 2013 May; 40(4):481-7. PubMed ID: 23618768
[TBL] [Abstract][Full Text] [Related]
7. Myristic Acid-Modified
Ying M; Wang S; Zhang M; Wang R; Zhu H; Ruan H; Ran D; Chai Z; Wang X; Lu W
ACS Appl Mater Interfaces; 2018 Jun; 10(23):19473-19482. PubMed ID: 29790744
[TBL] [Abstract][Full Text] [Related]
8. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
[TBL] [Abstract][Full Text] [Related]
9. (18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors.
Ma Y; Liang S; Guo J; Guo R; Wang H
J Labelled Comp Radiopharm; 2014 Sep; 57(11):627-31. PubMed ID: 25294311
[TBL] [Abstract][Full Text] [Related]
10. Design, preparation and biological evaluation of a
Behnammanesh H; Jokar S; Erfani M; Geramifar P; Sabzevari O; Amini M; Mazidi SM; Hajiramezanali M; Beiki D
Bioorg Chem; 2020 Jan; 94():103381. PubMed ID: 31662215
[TBL] [Abstract][Full Text] [Related]
11. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a
Zhang M; Lu L; Ying M; Ruan H; Wang X; Wang H; Chai Z; Wang S; Zhan C; Pan J; Lu W
Mol Pharm; 2018 Jun; 15(6):2437-2447. PubMed ID: 29734808
[TBL] [Abstract][Full Text] [Related]
13. iRGD-mediated core-shell nanoparticles loading carmustine and O
Liu C; Yao S; Li X; Wang F; Jiang Y
J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.
De K; Bhowmik A; Behera A; Banerjee I; Ghosh MK; Misra M
J Pept Sci; 2012 Dec; 18(12):720-30. PubMed ID: 23109400
[TBL] [Abstract][Full Text] [Related]
15. Stabilized Heptapeptide A7R for Enhanced Multifunctional Liposome-Based Tumor-Targeted Drug Delivery.
Ying M; Shen Q; Liu Y; Yan Z; Wei X; Zhan C; Gao J; Xie C; Yao B; Lu W
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13232-41. PubMed ID: 27195531
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool.
Zhang Q; Yang Z; Zhang J; Li Y; Dang X; Qu J; Pan X; Zhang J
Bioorg Chem; 2024 Apr; 145():107240. PubMed ID: 38412651
[TBL] [Abstract][Full Text] [Related]
17. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y
Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394
[TBL] [Abstract][Full Text] [Related]
18. Liposome-Based Systemic Glioma-Targeted Drug Delivery Enabled by All-d Peptides.
Ying M; Zhan C; Wang S; Yao B; Hu X; Song X; Zhang M; Wei X; Xiong Y; Lu W
ACS Appl Mater Interfaces; 2016 Nov; 8(44):29977-29985. PubMed ID: 27797175
[TBL] [Abstract][Full Text] [Related]
19. Involvement of reactive oxygen species and caspase-dependent pathway in berberine-induced cell cycle arrest and apoptosis in C6 rat glioma cells.
Chen TC; Lai KC; Yang JS; Liao CL; Hsia TC; Chen GW; Lin JJ; Lin HJ; Chiu TH; Tang YJ; Chung JG
Int J Oncol; 2009 Jun; 34(6):1681-90. PubMed ID: 19424587
[TBL] [Abstract][Full Text] [Related]
20. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
Cheng Z; Chen J; Quinn TP; Jurisson SS
Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
